Health in Tech, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Health in Tech's Q2 results show a revenue decline and increased expenses, with a new carrier transition impacting operations and a significant convertible financing agreement announced.
NASDAQ
Health In Tech reported a 9.4% year-over-year revenue increase to $8.8 million for Q1 2026, driven by its SMR segment, but experienced a widening net loss of $1.6 million.
NASDAQ
Health In Tech, Inc. announced significant revenue growth and strategic technology advancements in its Q3 2025 report, despite a temporary pause in its HI Card service.
NASDAQ
Health In Tech, Inc. announced significant revenue and profit growth for the first half of 2025, driven by new product demand and increased enrolled employees.
NASDAQ
Health In Tech's Q1 2025 shows significant revenue growth driven by new product offerings and expanded adoption of self-funded health plan solutions.